Home › Stocks › IONS US-listed stock · IONS
Ionis Pharmaceuticals, Inc. (IONS): trades by Congress and insiders
No trades disclosed in the last 12 months; 7 disclosures on record in all.
Congress trades 012 months
Members trading 012 months
Insider buys / sales 0 / 012 months 7 disclosed buys and sales on record since 20 January 2016. Insider counts are open-market trades only: awards, option exercises and tax withholding are left out.
Latest disclosures
Disclosed Filed by Type Amount Traded
17 Apr 2023 Daniel Goldman House · D-NY Sale $1K–$15K
6 Mar 2023
7 Apr 2023 Ro Khanna House · D-CA Sale $1K–$15K
14 Mar 2023
6 Jan 2023 Ro Khanna House · D-CA Buy $1K–$15K
6 Dec 2022
14 Oct 2021 Ro Khanna House · D-CA Buy $1K–$15K
28 Sep 2021
27 Apr 2020 Donna Shalala House · D-FL Buy $1K–$15K
8 May 2019
27 Apr 2020 Donna Shalala House · D-FL Sale $1K–$15K
24 Jun 2019
20 Jan 2016 Sheldon Whitehouse Senate · D-RI Sale $1K–$15K
20 Jan 2016
Columns are written from public disclosures: House and Senate periodic transaction reports, SEC Form 4, Japan’s EDINET large-holding reports and Taiwan’s insider registers and market data (TWSE, TPEx, MOPS and the central bank, with history from FinMind). Stock pages add SEC 13F fund holdings and company financials, analysts’ figures from Financial Modeling Prep and Finnhub, and lobbying and federal contract records from the Senate and USAspending.gov. Amounts are disclosed as ranges, so the figures are estimates. Nothing here is investment advice.
Home · Features · Columns · Members of Congress · Stocks · Sitemap · RSS feed of the columns · Privacy and security
Follow us on X Bluesky LinkedIn